| Overall cohort |
---|---|
Number | 97 |
Sex | |
 Male | 58.8% |
 Female | 41.2% |
Age at diagnosis in years | |
 Mean ± SD | 70.1 ± 8.3 |
Age at 1. CK SRS in years | |
 Mean ± SD | 73.3 ± 5.8 |
Years from diagnosis to CK SRS | |
 Mean ± SD | 3.2 ± 5.0 |
Number of lesions per treatment | |
 1 | 53.0% |
 2–4 | 39.9% |
 5–7 | 6.6% |
 8 | 0.5% |
Number of treatments per patient | |
 1 | 79.5% |
 2 | 16.4% |
  > 2 | 4.1% |
Pathologies | |
 Lung cancer | 40.2% |
 Renal cell carcinoma | 22.7% |
 Malignant melanoma | 15.5% |
 Breast cancer | 10.3% |
 Gastrointestinal tract | 3.1% |
 Others | 3.1% |
 Pharynx | 2.1% |
 Cancer of unknown pathology | 2.1% |
 Urothelial carcinoma | 1.0% |
Whole brain irradiation treatment (% of patients) | |
 Without | 83 (85.6%) |
 Prior to CK-SRS | 10 (10.3%) |
 After CK-SRS | 3 (3.1%) |
GPA Class | |
 2 | 5 (5.2%) |
 3 | 58 (59.8%) |
 4 | 34 (35.1%) |
Extracranial metastases at diagnosis | |
 Yes | 72 (74.2%) |
 No | 25 (25.8%) |